» Articles » PMID: 24555665

Molecular Epidemiology of Hepatitis B and Hepatitis Delta Viruses Circulating in the Western Amazon Region, North Brazil

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2014 Feb 22
PMID 24555665
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hepatitis B virus (HBV) and hepatitis D virus (HDV) represent important public health problems in the Western Amazon region with reported cases of fulminant hepatitis. This cross sectional study describes HBV and HDV genotypes circulating in the Brazilian Amazon region.

Methods: HBsAg positive individuals (n = 224) were recruited in Manaus/Amazonas State (130 blood donors from the Hematology and Hemotherapy Foundation from Amazonas/HEMOAM; 60 subjects from outpatient clinic) and in Eirunepe city (n = 34) from 2003-2009. Most participants (n = 153) lived in Manaus, 63 were from 20 remote isolated municipalities, 8 lived outside Amazonas State. Genotyping was based on PCR products: HBV genotype A-F specific primers, restricted length polymorphism for HDV. HDV isolates were directly sequenced (delta antigen 405 nucleotide fragment) and phylogenetic analysis performed (MEGA; neighbor-joining, Kimura's two parameter).

Results: Most participants were young adult males and HBV mono-infection predominated (70.5%, 158/224). Among blood donors, outpatient subjects and individuals from Eirunepe, HBV/A prevailed followed by HBV/D and F (p > 0.05). HBV/A was more frequent in blood donors (p < 0.05). HBV-HDV coinfection rate was 8.5% in blood donors (11/130), 65.0% (39/60) in outpatient subjects and 47.0% (16/34) in individuals from Eirunepe. Compared to blood donors, coinfection was higher in outpatient subjects (65.0% versus 8.5%; RR = 5.0; CI 3.4-7.9; p < 0.0001) and in subjects from Eirunepe (47.0% versus 8.5%; RR = 5.5; CI 3.0-9.9; p < 0.0001). HBV-HDV coinfection rates were higher in patients from highly endemic remote cities. Only HDV genotype 3 was detected, HBV/F-HDV/3 predominated (20/38; 52.7%), followed by HBV/A-HDV/3 (31.6%; 12/38) and HBV/D-HDV/3 (15.8%; 6/38).

Conclusions: The description of HBV and HDV genotypes circulating in the western Amazon can contribute to a better understanding of their relevance on the regional epidemics. These infections are highly endemic in the Amazon where their control is challenged by its vast territorial dimension with small, hard-to-reach municipalities dispersed into the jungle and populated by diverse ethnic groups.

Citing Articles

Unveiling Prevalence, Risk Factors, and Outcomes of Hepatitis D Among Vulnerable Communities in Romania.

Gheorghe L, Iacob S, Csiki I, Ghioca M, Iacob R, Constantinescu I Viruses. 2025; 17(1).

PMID: 39861841 PMC: 11769301. DOI: 10.3390/v17010052.


Prevalence and clinical characterization of hepatitis D virus (HDV) infection among Sudanese patients with hepatitis B virus (HBV): a cross-sectional study.

Alajab M, Ibn Auf B, Rafei A, Abdo A Ann Med Surg (Lond). 2024; 86(9):5091-5095.

PMID: 39239022 PMC: 11374274. DOI: 10.1097/MS9.0000000000002337.


Clinical profile and parameters of patients monoinfected with HBV and infected with HDV in Western Amazon.

Castro E Silva E, Roca T, Passos-Silva A, Borzacov L, Oliveira A, Queiroz J Heliyon. 2024; 10(10):e31065.

PMID: 38803893 PMC: 11128886. DOI: 10.1016/j.heliyon.2024.e31065.


Circulation of HDV Genotypes in Brazil: Identification of a Putative Novel HDV-8 Subgenotype.

Mello F, Barros T, Angelice G, Costa V, Mello V, Pardini M Microbiol Spectr. 2023; 11(3):e0396522.

PMID: 37074189 PMC: 10269522. DOI: 10.1128/spectrum.03965-22.


Low prevalence of hepatitis delta infection in Cuban HBsAg carriers: Prospect for elimination.

de Los Angeles Rodriguez Lay L, Tan Z, Villalba M, Suarez M, Corredor M, Hernandez D Front Med (Lausanne). 2023; 9:1069372.

PMID: 36816726 PMC: 9928864. DOI: 10.3389/fmed.2022.1069372.


References
1.
Gish R, Gadano A . Chronic hepatitis B: current epidemiology in the Americas and implications for management. J Viral Hepat. 2006; 13(12):787-98. DOI: 10.1111/j.1365-2893.2006.00787.x. View

2.
Wedemeyer H, Manns M . Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol. 2010; 7(1):31-40. DOI: 10.1038/nrgastro.2009.205. View

3.
Yu H, Yuan Q, Ge S, Wang H, Zhang Y, Chen Q . Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "I". PLoS One. 2010; 5(2):e9297. PMC: 2824819. DOI: 10.1371/journal.pone.0009297. View

4.
Fonseca J . [Hepatitis D]. Rev Soc Bras Med Trop. 2002; 35(2):181-90. DOI: 10.1590/s0037-86822002000200009. View

5.
Farci P, Niro G . Clinical features of hepatitis D. Semin Liver Dis. 2012; 32(3):228-36. DOI: 10.1055/s-0032-1323628. View